ResMed Inc.RMDNYSE
Loading
Net Income Growth Recovery in ProgressRecovering
Percentile Rank79
3Y CAGR+22.6%
5Y CAGR+81.6%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+22.6%/yr
vs -52.0%/yr prior
5Y CAGR
+81.6%/yr
Recent deceleration
Acceleration
+74.6pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
19.7x
Strong expansion
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 12.64% |
| Q3 2025 | -8.21% |
| Q2 2025 | 4.02% |
| Q1 2025 | 5.93% |
| Q4 2024 | 10.68% |
| Q3 2024 | 6.54% |
| Q2 2024 | -2.75% |
| Q1 2024 | 43.91% |
| Q4 2023 | -4.84% |
| Q3 2023 | -4.46% |
| Q2 2023 | -1.22% |
| Q1 2023 | 3.37% |
| Q4 2022 | 6.86% |
| Q3 2022 | 7.90% |
| Q2 2022 | 8.97% |
| Q1 2022 | -11.27% |
| Q4 2021 | -0.91% |
| Q3 2021 | 4.36% |
| Q2 2021 | 348.59% |
| Q1 2021 | -143.72% |
| Q4 2020 | 0.64% |
| Q3 2020 | 0.30% |
| Q2 2020 | 9.01% |
| Q1 2020 | 1.61% |
| Q4 2019 | 33.63% |
| Q3 2019 | 74.64% |
| Q2 2019 | -34.74% |
| Q1 2019 | -15.42% |
| Q4 2018 | 17.88% |
| Q3 2018 | -3.71% |
| Q2 2018 | -0.28% |
| Q1 2018 | 1055.93% |
| Q4 2017 | -88.94% |
| Q3 2017 | -15.24% |
| Q2 2017 | 15.70% |
| Q1 2017 | 14.44% |
| Q4 2016 | 0.84% |
| Q3 2016 | -8.44% |
| Q2 2016 | -8.44% |
| Q1 2016 | -5.01% |